Alliance HealthCare Services, Inc. (NYSE:AIQ) (the “Company” or “Alliance”), a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the third quarter ended September 30, 2011.

Third Quarter 2011 Financial Results

Revenue for the third quarter of 2011 was $126.8 million compared to $121.1 million in the third quarter of 2010, an increase of 4.7%. On a sequential quarter basis, revenue decreased (0.8%) to $126.8 million in the third quarter of 2011 compared to $127.8 million in the second quarter of 2011.

Alliance’s Adjusted EBITDA (as defined below) was $38.5 million in the third quarter of 2011 compared to $40.4 million in the third quarter 2010, a decrease of 4.7%. On a sequential quarter basis, Adjusted EBITDA was steady at $38.5 million in the third quarter of 2011 compared to $38.8 million in the second quarter of 2011.

Alliance’s net loss, computed in accordance with generally accepted accounting principles (“GAAP”), totaled ($137.3) million in the third quarter of 2011, including ($133.0) million of non-cash impairment charges net of tax, and ($1.0) million in the third quarter of 2010.

Net loss per share on a diluted basis, computed in accordance with GAAP, was ($2.58) per share in the third quarter of 2011 and ($0.02) per share in the third quarter of 2010. In the third quarter of 2011, net loss per share on a diluted basis was impacted by ($2.55) in the aggregate due to non-cash impairment charges, restructuring charges, severance and related costs, mergers and acquisitions transaction costs and a lower GAAP income tax rate than our historical income tax rate. Alliance’s historical income tax rate has been approximately 42%, rather than the GAAP income tax rate of 16.2% in the third quarter of 2011.

The third quarter of 2011 included non-cash impairment charges totaling $155.7 million, or $133.0 million net of tax, related to Alliance’s imaging division. Alliance completed step one of its impairment analysis which indicated impairment as of September 30, 2011 and therefore began, but has not completed, the subsequent steps to quantify a final goodwill impairment charge. However, management’s best estimate of a goodwill impairment charge is $153.0 million, and $2.7 million related to impairment of certain intangible assets. The impairment charge is based on a preliminary analysis and may be subject to further adjustments. During the fourth quarter, the Company intends to complete the valuation work to determine the fair value of the imaging division assets and liabilities and record adjustments to their estimate, if any. Alliance believes that the reduction in fair value which prompted the impairment charges is a result of sustained high unemployment rates, a reported decline in physician office visits, and other conditions in the United States arising from global economic conditions. These factors have had a sustained negative impact on the Company’s stock price and on the fair value of its imaging division reporting unit. As a result, Alliance recorded the estimated non-cash impairment charges in the third quarter of 2011. These impairment charges are non-cash expenses and will not have any impact on the Company's cash position, future cash flows or debt covenants.

Cash flows provided by operating activities were $24.4 million in the third quarter of 2011 compared to $32.6 million in the third quarter of 2010, and $27.2 million in the second quarter of 2011. Capital expenditures in the third quarter of 2011 were $15.0 million compared to $15.6 million in the third quarter of 2010.

Cash and cash equivalents were $40.3 million at September 30, 2011 and $97.2 million at December 31, 2010.

Alliance’s net debt, defined as total long-term debt (including current maturities) less cash and cash equivalents, increased $50.8 million to $606.9 million at September 30, 2011 from $556.1 million at December 31, 2010. In connection with the recently announced amendment to the Company’s credit agreement, the Company paid down $25.0 million of borrowings outstanding under the Company’s term loan facility and paid $6.0 million to the consenting lenders and other amendment related fees. In addition, the Company used approximately $42.0 million in cash; net of cash acquired, and assumed $26.0 million in equipment debt in connection with the acquisition of US Radiosurgery in April 2011. The Company also used approximately $5.0 million in cash in connection with the acquisition of assets from 24/7 Radiology in April 2011. The Company’s net debt, as defined above, divided by the last twelve months Adjusted EBITDA, was 4.07x for the twelve month period ended September 30, 2011.

The Company’s total long-term debt (including current maturities) decreased to $647.3 million at September 30, 2011 from $653.3 million at December 31, 2010. The Company’s total long-term debt (including current maturities) divided by last twelve months Adjusted EBITDA (computed based on the definition thereof in the Company’s amended Credit Agreement) was 4.45x for the twelve month period ended September 30, 2011.

Paul S. Viviano, Chairman of the Board and Chief Executive Officer, stated, “Alliance continues to focus on the three critical elements of our improvement plan. The Imaging Division strategy includes improving renewals of existing customers, driving new sales, and providing service in a more cost effective manner through recently disclosed expense reduction programs. Alliance Oncology continues to experience same customer volume growth, while focused on opening new de novo linear accelerator and stereotactic radiosurgery facilities. We continue to be diligent regarding the cost savings initiatives across the entire organization, for which we expect to realize $20 to $25 million of annualized savings phased in over an approximate two-year period. In the third quarter of 2011 we achieved $11 million dollars of annualized savings, which exceeded our target of $10 million dollars. Finally, the Company continues to evaluate selective acquisition opportunities in a disciplined manner.”

Full Year 2011 Guidance

Alliance is reaffirming the full year 2011 revenue, Adjusted EBITDA, fixed-site center openings, and radiation therapy center openings guidance ranges. The Company is also updating its full year 2011 guidance ranges for cash capital expenditures and decrease in long-term debt, net of the change in cash and cash equivalents (before investments in acquisitions and debt financing costs) as follows:
        Updated
Guidance Guidance
Ranges Ranges
(dollars in millions) (dollars in millions)
Revenue $475 - $495
Adjusted EBITDA $140 - $150
Cash capital expenditures $35 - $45 $45 - $55
Decrease in long-term debt, net of the change in cash
and cash equivalents (before investments in acquisitions and
debt financing costs) $20 - $30 $10 - $20
Fixed-site imaging center openings 12 - 16
Radiation therapy center openings 2 - 4
 

Third Quarter 2011 Earnings Conference Call

Investors and all others are invited to listen to a conference call discussing third quarter 2011 results. The conference call is scheduled for Wednesday, November 9, 2011 at 8:30 a.m. Eastern Time. The call will be broadcast live on the Internet and can be accessed by visiting the Company’s website at www.alliancehealthcareservices-us.com. Click on Audio Presentations in the Investors section of the website to access the link.

The conference call can be accessed at (888) 694-4676 (United States) or (973) 582-2737 (International). Interested parties should call at least 5 minutes prior to the call to register. A telephone replay will be available until December 9, 2011. The telephone replay can be accessed by calling (855) 859-2056 (United States) or (404) 537-3406 (International). The conference call identification number is 20594655.

Definition of Adjusted EBITDA

Adjusted EBITDA, as defined by the Company’s management, represents net income (loss) before: interest expense, net of interest income; income taxes; depreciation expense; amortization expense; net income (loss) attributable to noncontrolling interests; non-cash share-based compensation; severance and related costs; restructuring charges; loss on extinguishment of debt; fees and expenses related to acquisitions; non-cash impairment charges; and other non-cash charges included in other (income) expense, net, which includes non-cash losses on sales of equipment. The components used to reconcile net income (loss) to Adjusted EBITDA are consistent with our historical presentation of Adjusted EBITDA. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles in the United States, or “GAAP.” For a more detailed discussion of Adjusted EBITDA and reconciliation to net income (loss), see the section entitled “Adjusted EBITDA” included in the tables following this release.

About Alliance HealthCare Services

Alliance HealthCare Services is a leading national provider of advanced outpatient diagnostic imaging and radiation therapy services based upon annual revenue and number of systems deployed. Alliance focuses on MRI, PET/CT and CT through its Imaging division and radiation therapy through its Oncology division. With more than 2,300 team members committed to providing exceptional patient care and exceeding customer expectations, Alliance provides quality clinical services for over 1,000 hospitals and other healthcare partners in 45 states. Alliance operates 570 diagnostic imaging and radiation therapy systems. The Company is the nation’s largest provider of advanced diagnostic mobile imaging services and one of the leading operators of fixed-site imaging centers, with 135 locations across the country. Alliance also operates 37 radiation therapy centers, including 16 dedicated stereotactic radiosurgery facilities, many of which are operated in conjunction with local community hospital partners, providing treatment and care for cancer patients. With 16 stereotactic radiosurgery facilities in operation, Alliance is among the leading providers of stereotactic radiosurgery nationwide.

Forward-Looking Statements

This press release contains forward-looking statements relating to future events, including statements related to forecasted annualized revenue from new client contracts in the Company’s revenue gap disclosures, investment, development and acquisition activity, the implementation of strategic initiatives, the integration of acquired businesses into the Company, the implementation and potential savings from the Company’s organizational restructure, the Company’s ability to operate and grow its Oncology division, the opening of new imaging and radiation oncology centers, and the Company’s full year 2011 guidance. In this context, forward-looking statements often address the Company’s expected future business and financial results and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks” or “will.” Forward-looking statements by their nature address matters that are uncertain and subject to risks. Such uncertainties and risks include: changes in the preliminary financial results and estimates due to the restatement or review of the Company’s financial statements; the nature, timing and amount of any restatement or other adjustments; the Company’s ability to make timely filings of its required periodic reports under the Securities Exchange Act of 1934; issues relating to the Company’s ability to maintain effective internal control over financial reporting and disclosure controls and procedures; the Company’s high degree of leverage and its ability to service its debt; factors affecting the Company’s leverage, including interest rates; the risk that the counterparties to the Company’s interest rate swap agreements fail to satisfy their obligations under these agreements; the Company’s ability to obtain financing; the effect of operating and financial restrictions in the Company’s debt instruments; the accuracy of the Company’s estimates regarding its capital requirements; the effect of intense levels of competition in the Company’s industry; changes in the methods of third party reimbursements for diagnostic imaging and radiation oncology services; fluctuations or unpredictability of the Company’s revenues, including as a result of seasonality; changes in the healthcare regulatory environment; the Company’s ability to keep pace with technological developments within its industry; the growth in the market for MRI and other services; the disruptive effect of hurricanes and other natural disasters; adverse changes in general domestic and worldwide economic conditions and instability and disruption of credit markets; difficulties the Company may face in connection with recent, pending or future acquisitions, including unexpected costs or liabilities resulting from the acquisitions, diversion of management’s attention from the operation of the Company’s business, and risks associated with integration of the acquisitions; and other risks and uncertainties identified in the Risk Factors section of the Company’s Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission (the “SEC”), as may be modified or supplemented by our subsequent filings with the SEC. These uncertainties may cause actual future results or outcomes to differ materially from those expressed in the Company’s forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake to update its forward-looking statements except as required under the federal securities laws.
         
 
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(in thousands, except per share amounts)
 
Quarter Ended Nine Months Ended
September 30, September 30,
2010 2011 2010 2011
 
Revenues $ 121,090 $ 126,791 $ 361,158 $ 372,999
 
Costs and expenses:

Cost of revenues, excluding depreciation and amortization
66,304 71,819 196,711 210,579
Selling, general and administrative expenses 16,915 19,760 49,546 56,707
Transaction costs 756 1,135 1,543 3,317
Severance and related costs 303 2,779 846 3,509
Impairment charges - 155,703 - 155,703
Depreciation expense 22,995 22,710 69,780 67,959
Amortization expense 3,308 4,330 9,201 12,265
Interest expense and other, net 12,629 12,436 38,752 36,171
Other (income) and expense, net   (299 )   533     (627 )   663  
Total costs and expenses   122,911     291,205     365,752     546,873  

Loss before income taxes, earnings from unconsolidated investees, and noncontrolling interest
(1,821 ) (164,414 ) (4,594 ) (173,874 )
Income tax benefit (799 ) (26,561 ) (1,485 ) (30,141 )
Earnings from unconsolidated investees   (922 )   (716 )   (2,900 )   (2,736 )
Net loss (100 ) (137,137 ) (209 ) (140,997 )
Less: Net income attributable to noncontrolling interest   (880 )   (133 )   (2,854 )   (2,716 )
Net loss attributable to Alliance HealthCare Services, Inc. $ (980 ) $ (137,270 ) $ (3,063 ) $ (143,713 )
 
Comprehensive loss, net of taxes
Net loss attributable to Alliance HealthCare Services, Inc. $ (980 ) $ (137,270 ) $ (3,063 ) $ (143,713 )
Unrealized gain (loss) on hedging transactions, net of taxes   467     (103 )   1,095     (304 )
Comprehensive loss, net of taxes: $ (513 ) $ (137,373 ) $ (1,968 ) $ (144,017 )
 
Loss per common share attributable to Alliance HealthCare Services, Inc.:
Basic $ (0.02 ) $ (2.58 ) $ (0.06 ) $ (2.70 )
Diluted $ (0.02 ) $ (2.58 ) $ (0.06 ) $ (2.70 )
 

 

Weighted average number of shares of common stock and common stock equivalents:
Basic 52,762 53,198 52,755 53,143
Diluted 52,762 53,198 52,755 53,143
 
 
 
 
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
  December 31,     September 30,
2010 2011
ASSETS
Current assets:
Cash and cash equivalents $ 97,162 $ 40,334
Accounts receivable, net of allowance for doubtful accounts 62,956 74,445
Deferred income taxes 7,344 7,344
Prepaid expenses 9,802 7,015
Other receivables   3,594     5,938  
Total current assets 180,858 135,076
 
Equipment, at cost 902,829 949,514
Less accumulated depreciation   (591,145 )   (643,009 )
Equipment, net 311,684 306,505
 
Goodwill 193,126 57,863
Other intangible assets, net 94,622 145,853
Deferred financing costs, net 14,883 18,170
Other assets   21,028     27,468  
Total assets $ 816,201   $ 690,935  
 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable $ 15,541 $ 20,548
Accrued compensation and related expenses 17,061 16,173
Accrued interest payable 5,812 9,502
Other accrued liabilities 37,138 36,167
Current portion of long-term debt   9,709     24,582  
Total current liabilities 85,261 106,972
 
Long-term debt, net of current portion 455,747 434,647
Senior notes 187,809 188,031
Other liabilities 1,229 1,343
Deferred income taxes   72,496     48,264  
Total liabilities 802,542 779,257
 
Stockholders’ equity (deficit):
Common stock 525 526
Treasury stock (2,551 ) (2,636 )
Additional paid-in capital 16,062 19,365
Accumulated comprehensive loss (669 ) (973 )
Accumulated deficit   (11,176 )   (154,889 )
Total stockholders’ equity (deficit) attributable to Alliance HealthCare Services, Inc. 2,191 (138,607 )
Noncontrolling interest   11,468     50,285  
Total stockholders’ equity (deficit)   13,659     (88,322 )
Total liabilities and stockholders’ equity (deficit) $ 816,201   $ 690,935  
 
 
 
 
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands)
 

Nine Months Ended September 30,
2010     2011
Operating activities:
Net loss $ (209 ) $ (140,997 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Provision for doubtful accounts 615 3,292
Share-based payment 4,189 3,718
Depreciation and amortization 78,981 80,224
Impairment charges - 155,703
Amortization of deferred financing costs and other 2,037 2,984
Accretion of discount on long term debt 1,140 1,196
Adjustment of derivatives to fair value 81 (42 )
Distributions greater than (less than) undistributed earnings from investees 1,125 (1,026 )
Deferred income taxes (2,230 ) (30,206 )
(Gain) loss on sale of assets (627 ) 852
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable (4,696 ) (9,600 )
Prepaid expenses 847 3,240
Other receivables 1,034 (2,323 )
Other assets 225 (436 )
Accounts payable (4,742 ) 3,609
Accrued compensation and related expenses 1,299 (1,386 )
Accrued interest payable 5,766 3,616
Income taxes payable 85 59
Other accrued liabilities   179     (1,433 )
Net cash provided by operating activities   85,099     71,044  
 
Investing activities:
Equipment purchases (43,835 ) (36,116 )
(Increase) decrease in deposits on equipment (1,956 ) 1,068
Acquisitions, net of cash received (32,221 ) (47,913 )
Decrease in cash in escrow 485 1,063
Investment in unconsolidated joint venture (250 ) -
Proceeds from sale of assets   2,178     392  
Net cash used in investing activities   (75,599 )   (81,506 )
 
 
 
 
ALLIANCE HEALTHCARE SERVICES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(Unaudited)
(in thousands)
     

Nine Months Ended September 30,
2010 2011
 
Financing activities:
Principal payments on equipment debt (5,317 ) (8,079 )
Proceeds from equipment debt 358 1,600
Principal payments on term loan facility (3,450 ) (28,450 )
Principal payments on senior subordinated notes (5,582 ) -
Payments of debt issuance and amendment costs (416 ) (6,271 )
Payments of contingent consideration - (1,626 )
Noncontrolling interest in subsidiaries (3,382 ) (3,509 )
Proceeds from shared-based payment arrangements 76 54
Purchase of treasury stock   (47 )   (85 )
Net cash used in financing activities   (17,760 )   (46,366 )
 
Net decrease in cash and cash equivalents (8,260 ) (56,828 )
Cash and cash equivalents, beginning of period   111,884     97,162  
Cash and cash equivalents, end of period $ 103,624   $ 40,334  
 
 
Supplemental disclosure of cash flow information:
Interest paid $ 28,361 $ 29,228
Income taxes paid, net of refunds 165 (2,335 )
 
Supplemental disclosure of non-cash investing and financing activities:
Net book value of assets exchanged $ 1,602 $ 45
Capital lease obligations related to the purchase of equipment 575 2,461
Capital lease obligations transferred - (706 )
Comprehensive gain (loss) from hedging transactions, net of taxes 1,095 (304 )
Equipment debt assumed in connection with acquisitions - 25,973
Equipment purchases in accounts payable 585 317
Contingent consideration for acquisitions 3,958 -
Noncontrolling interest assumed in connection with acquisitions 5,036 39,610
 
 

ALLIANCE HEALTHCARE SERVICES, INC. ADJUSTED EBITDA (in thousands)

Adjusted EBITDA, as defined by the Company’s management, represents net income (loss) before: interest expense, net of interest income; income taxes; depreciation expense; amortization expense; net income (loss) attributable to noncontrolling interests; non-cash share-based compensation; severance and related costs; restructuring charges; loss on extinguishment of debt; fees and expenses related to acquisitions, costs related to debt financing, non-cash impairment charges, and other non-cash charges included in other (income) expense, net, which includes non-cash losses on sales of equipment. The components used to reconcile net income (loss) to Adjusted EBITDA are consistent with our historical presentation of Adjusted EBITDA. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles in the United States, or “GAAP.”

Management uses Adjusted EBITDA, and believes it is a useful measure for investors, for a variety of reasons. Management regularly communicates its Adjusted EBITDA results and management’s interpretation of such results to its board of directors. Management also compares the Company’s Adjusted EBITDA performance against internal targets as a key factor in determining cash incentive compensation for executives and other employees, largely because management feels that this measure is indicative of how our diagnostic imaging and radiation oncology business is performing and is being managed. Management believes that Adjusted EBITDA is a particularly useful comparative measure within the Company’s industry. The diagnostic imaging and radiation oncology industry continues to experience significant consolidation. These activities have led to significant charges to earnings, such as those resulting from acquisition costs, and to significant variations among companies with respect to capital structures and cost of capital (which affect interest expense) and differences in taxation and book depreciation of facilities and equipment (which affect relative depreciation expense), including significant differences in the depreciable lives of similar assets among various companies. In addition, management believes that because of the variety of equity awards used by companies, the varying methodologies for determining non-cash share-based compensation expense among companies and from period to period, and the subjective assumptions involved in that determination, excluding non-cash share-based compensation from Adjusted EBITDA enhances company-to-company comparisons over multiple fiscal periods and enhances the Company’s ability to analyze the performance of its diagnostic imaging and radiation oncology business.

Adjusted EBITDA may not be directly comparable to similarly titled measures reported by other companies. In addition, Adjusted EBITDA has other limitations as an analytical financial measure. These limitations include the fact that Adjusted EBITDA is calculated before recurring cash charges including interest expense, income taxes and severance costs, and is not adjusted for capital expenditures, the replacement cost of assets or other recurring cash requirements of the Company’s business. Adjusted EBITDA also does not reflect any cost for equity awards to employees and does not exclude income attributable to noncontrolling interests. In the future, the Company expects that it may incur expenses similar to the excluded items discussed above. Accordingly, the exclusion of these and other similar items in the Company’s non-GAAP presentation should not be interpreted as implying that these items are non-recurring, infrequent or unusual. Management compensates for the limitations of using Adjusted EBITDA as an analytical measure by relying on the Company’s GAAP results to evaluate its operating performance and by considering independently the economic effects of the items that are or are not reflected in Adjusted EBITDA. Management also compensates for these limitations by providing GAAP-based disclosures concerning the excluded items in the Company’s financial disclosures. As a result of these limitations, however, Adjusted EBITDA should not be considered as an alternative to net income (loss), as calculated in accordance with GAAP, or as an alternative to any other GAAP measure of operating performance.

The calculation of Adjusted EBITDA is shown below:

              Twelve months
Third Quarter Ended September 30, Nine Months Ended September 30, Ended September 30,
2010 2011 2010 2011 2011

Net loss attributable to

Alliance HealthCare Services, Inc.
$ (980) $ (137,270) $ (3,063) $ (143,713) $ (173,303)
Income tax benefit (799) (26,561) (1,485) (30,141) (49,455)
Interest expense and other, net 12,629 12,436 38,752 36,171 48,622
Amortization expense 3,308 4,330 9,201 12,265 15,503
Depreciation expense 22,995 22,710 69,780 67,959 90,500
Share-based payment (included in
selling, general and administrative expenses) 1,329 1,061 4,159 3,657 5,014
Severance and related costs 303 20 846 750 906
Noncontrolling interest in subsidiaries 880 133 2,854 2,716 3,752
Restructuring charges - 3,597 - 3,597 3,597
Transaction costs 756 1,355 1,543 3,537 4,433
Impairment charges - 155,703 - 155,703 197,798
Other non-cash charges (included in other (income)
and expenses, net) 3 994 511 1,361 1,453
Adjusted EBITDA $ 40,424 $ 38,508 $ 123,098 $ 113,862 $ 148,820
 

The total leverage ratio calculation for the 12 months ended September 30, 2011 is shown below:
            Less:  
Noncontrolling
interest in Credit
Consolidated Subsidiaries Agreement
Total debt $ 647,260 $ - $ 647,260
Less: Cash and cash equivalents   (40,334 )   -     (40,334 )
Net debt 606,926 - 606,926
 
Last 12 months Adjusted EBITDA 148,820 (3,752 ) 145,068
Pro forma acquisitions in last 12 month period (1)   399     -     399  
Last 12 months Adjusted EBITDA, as adjusted 149,219 (3,752 ) 145,467
 
Total leverage ratio 4.34x 4.45x
Net leverage ratio 4.07x 4.17x

__________(1) Gives pro-forma effect to acquisitions occurring during the last twelve months pursuant to the terms of the Credit Agreement.

The reconciliation from net loss to Adjusted EBITDA for the 2011 guidance range is shown below (in millions):

          2011 Full Year
Guidance Range
Net loss ($151 )   ($147 )
Income tax benefit (40 ) (37 )
Impairment charges 156 156
Depreciation expense; amortization expense; interest
expense and other, net; share-based payment and other expenses   175       178  
Adjusted EBITDA $ 140     $ 150  
 
 
 

ALLIANCE HEALTHCARE SERVICES, INC.

SELECTED STATISTICAL INFORMATION
 
Third Quarter Ended
September 30,

2010
   

2011
MRI
Average number of total systems 285.0 292.2
Average number of scan-based systems 242.1 247.7
Scans per system per day (scan-based systems) 8.24 7.97
Total number of scan-based MRI scans 128,913 124,507
Price per scan $ 380.87 $ 366.27
 
Scan-based MRI revenue (in millions) $ 49.1 $ 45.6
Non-scan based MRI revenue (in millions)   5.0   5.5
Total MRI revenue (in millions) $ 54.1 $ 51.1
 
PET and PET/CT
Average number of systems 118.0 122.8
Scans per system per day 5.59 5.26
Total number of PET and PET/CT scans 43,401 40,769
Price per scan $ 1,047 $ 1,020
 
Total PET and PET/CT revenue (in millions) $ 45.8 $ 42.1
 
Radiation oncology
Linear accelerator treatments 20,456 22,975
Cyberknife patients 174 524
 
Total radiation oncology revenue (in millions) $ 11.7 $ 21.3
 
Revenue breakdown (in millions)
Total MRI revenue $ 54.1 $ 51.1
PET and PET/CT revenue 45.8 42.1
Radiation oncology revenue 11.7 21.3
Other modalities and other revenue   9.5   12.3
Total revenues $ 121.1 $ 126.8
 
Total fixed-site revenue (in millions)

2010

2011
Third quarter ended September 30 $ 30.3 $ 31.1
 
 

ALLIANCE HEALTHCARE SERVICES, INC. SELECTED STATISTICAL INFORMATION IMAGING DIVISION REVENUE GAP (in millions)

The Company utilizes the imaging division revenue gap as a statistical measure of its client losses and new client contracts. The imaging division revenue gap is calculated by measuring the difference between (a) the imaging division annualized revenue run rate lost as a result of clients choosing to terminate contracts with the Company, excluding clients for which Alliance provides professional radiology services, interim services and clients that the Company elects to terminate, and (b) projected new imaging division annualized revenue from new client contracts, excluding professional radiology services and interim services, commencing service in the quarter.

The annualized revenue run rate lost from customers choosing to terminate service may not be representative of the revenues such customers would have generated had they remained our customers.

The projected annualized revenue from new client contracts is calculated using contractual pricing where agreed upon, and assumptions with respect to pricing and reimbursement levels for all other new customer relationships. The projected annualized revenue from new client contracts is also calculated using assumptions with respect to customer ramp-up and scan volumes. Our assumptions are based on our experience in the industry and our expectations with respect to pricing and volume trends, and may not reflect actual revenue from new clients for a number of reasons, including greater than expected macroeconomic challenges impacting the imaging business, the variance in ramp-up time of customers adding new service lines, unexpected changes in business conditions and greater than expected competition for imaging services. See “Forward-Looking Statements” for a discussion of the other risks and uncertainties that may cause actual future results or outcomes to differ materially from those expressed above.

The imaging division revenue gap for the last four calendar quarters and the last twelve month period ended September 30, 2011 is as follows:
                   
(a) (b)
Revenue New Imaging Division
Lost Revenue Revenue Gap

2010
Fourth Quarter ($8.4 ) $ 7.0 ($1.4 )
 

2011
First Quarter (5.1 ) 12.9 7.8
Second Quarter (13.3 ) 3.8 (9.5 )
Third Quarter (8.3 ) 2.3 (6.0 )
 
Last Twelve Months Ended
September 30, 2011 ($35.1 ) $ 26.0 ($9.1 )
 

Copyright Business Wire 2010